2009 Buick Enclave CXL
3.6 L • 6 • FWD • AT
5GAER23D39J181710
Sales history: 1
• $300Highlights
Condition
Run and drive
Seller
Insurance • State Farm Insurance
Key included
Yes
Docs
Good
History
1 record
Drive
3.6 L • 6 • FWD • AT
Odometer
291,301 mi ≈ 468,802 km
Primary damage
Side
Docs
IL • Salvage
Extra
Auction
VIN
5GAER23D39J181710
Lot number
84420925
Copart
Sale status
Sold
Seller type
Insurance
Seller
State Farm Insurance
Location
Southern Illinois, IL
Description
Fuel type
Gasoline
Body color
Tan
Body type
SUV
Generation
Lambda
Trim
CXL
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Buick models
2009 Buick Enclave CXL • 3.6 L • 6 cyl • FWD • Automatic • Copart Lot: 84420925 • VIN: 5GAER23D39J181710
Find out more about this 2009 Buick Enclave CXL, available at the Copart salvage car auction as lot 84420925 in Southern Illinois, IL. This car has Side main damage. It is listed with Run and drive start condition code. Odometer shows 291,301 mi. This Tan Buick Enclave SUV is equipped with Gasoline 3.6 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 5GAER23D39J181710 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
